Wiley's 2025 Key Trade Developments Series: Trade Remedies
Wiley's 2025 Key Trade Developments Series: U.S.-Mexico-Canada Agreement (USMCA)
What's the Buzz in the Battery World With Roger Miksad, BCI – Battery + Storage Podcast
Episode 365 -- Four Sanctions Cases Everyone Should Know
Compliance Tip of the Day: The Role of Supply Chain and Compliance in Tariffs
CHPS Podcast Episode 3: Unlocking America's Mineral Potential
Compliance Tip of the Day: Role of Compliance in Upcoming Trade Wars
Tariffs and Trade Series: Effects on Agriculture Operations and Markets
Episode 364 -- Five Strategies to Mitigate a New Risk Environment
Daily Compliance News: April 11, 2025 The Tariff Rollback Edition
Podcast - The "I" in FOCI and AI: Innovation, Intelligence, Influence
Cobalt, Lithium, and the Quest for Sustainable Batteries With John Busbee, Xerion — Battery + Storage Podcast
Emerging Risks & Opportunities: Navigating Environmental & Sustainability Regulations During the First 100 Days
You've got Questions
Episode 358 - Ethics and Compliance Trends for 2025: Is Your Company Prepared?
Government Contracts and New Mandates Executive Orders and Cost Recovery Strategies Explained
Mitigating FOCI Under Section 847
Supply Chain Labor Risk
Riskology by Infortal: Episode 34 – The Hezbollah Pager Attack & Supply Chain Compliance
Why Privacy is Your Secret Weapon Against Third-Party Risk
Private Equity focused on investment and operations within the Life Science industry faces significant compliance, operational and business risk due to the heavily regulated nature of the investment targets and portfolio...more
The U.S. government is pushing to redomesticate the manufacturing of pharmaceutical, biotech, gene therapy, and medical device products, both to bolster U.S. manufacturing generally and to address continuing shortages of...more
The Fedtrade® podcast recently interviewed Adam Boltik, Program Manager for the Office of International Commerce of the State of New Hampshire Department of Business and Economic Affairs, as part of our SelectUSA Investment...more
Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the world’s leading producer of gene-sequencing machines, from importing its gene...more
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....more